Freudenberg strengthens commitment to India

New Delhi [India], November 26: Freudenberg, a worldwide technology business based in Germany, will attend CPhI...

Watsons-Marlow unveils Qdos™ H-FLO and WMArchitect™

Singapore, September 19: Watson-Marlow Fluid Technology Solutions (WMFTS), a world leader in manufacturing...

Lawmakers express concerns over US pharma companies'

Several lawmakers have urged the US Food and Drug Administration to initiate an investigation over US...

Prestige Biopharma's Tuznue Receives Positive CHMP Opinion

Singapore, August 1: Prestige Biopharma, a pioneer in biopharmaceuticals, announced that the Committee for Medicinal...

USAID and Takeda Launch Dengue Prevention Campaign

New Delhi [India], July 26: The United States Agency for International Development (USAID) and Takeda...

India, US to initiate new cooperation in quantum technology

The Biden administration also affirmed to lower barriers to US exports to India for high-performance computing...

GVSAP and Biocytogen Forge Strategic Collaboration

Hyderabad (Telangana) [India], May 17: GV Safety Assessment Platform (GVSAP), a leading integrated R&D enabler...

VAV Lipids Meets Global Demand for Pharmaceutical Egg Yolk Lecith

Mumbai (Maharashtra) [India], April 23: VAV Lipids, India's leading biopharmaceuticals and speciality ingredient...

Bharat Biotech begins clinical trials of TB vaccine ‘MTBVAC’

As per Bharat Biotech, MTBVAC is the first vaccine against Tuberculosis derived from a human source by the...

Nexobrid: A revolutionary treatment for burns to treat patients

The Bharat Serums and Vaccines (BSV), a biopharmaceutical company in India, inked an exclusive distribution...

IIL launches India's first Hepatitis A Vaccine 'Havisure'

Indian Immunologicals Ltd. (IIL), a wholly-owned subsidiary of the National Dairy Development Board (NDDB) and a...

PlasmaGen Biosciences completes INR 225 crores equity financing

Bengaluru (Karnataka) [India], December 15: PlasmaGen Biosciences ('PlasmaGen'), a biopharmaceutical company focused...